RELAY THERAPEUTICS INC. - COMMON STOCK

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates

05 مايو 2025 13:05:18 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025

28 أبريل 2025 13:05:39 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

26 فبراير 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

24 فبراير 2025 13:05:56 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025

19 فبراير 2025 13:05:31 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

07 يناير 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival

11 ديسمبر 2024 03:00:00 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium

09 ديسمبر 2024 13:05:30 بحسب Nasdaq GlobeNewswire

Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors

03 ديسمبر 2024 05:00:15 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Upcoming Investor Conferences

07 نوفمبر 2024 13:05:11 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights

06 نوفمبر 2024 13:05:29 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024

30 أكتوبر 2024 13:05:26 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

10 سبتمبر 2024 17:21:51 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces Proposed Public Offering of Common Stock

09 سبتمبر 2024 13:34:20 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival

09 سبتمبر 2024 03:55:20 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024

06 سبتمبر 2024 13:05:36 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

06 أغسطس 2024 13:05:26 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024

30 يوليو 2024 13:05:38 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Discloses Three New Programs at New Program & Platform Event

06 يونيو 2024 04:00:00 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608

05 يونيو 2024 13:05:03 بحسب Nasdaq GlobeNewswire